Healthcare Sector Stocks
The Healthcare sector has a total of 1059 stocks, with a combined market cap of $9.62 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 51.60.
Market Cap
9.62T
Revenue
4.66T
Profits
186.45B
PE Ratio
51.60
Profit Margin
4.00%
Dividend Yield
0.37%
1059 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.12T | 0.88% | 2,505,046 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 651.25B | 1.07% | 6,185,884 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 468.22B | 1.20% | 5,156,549 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 376.37B | 2.39% | 15,971,361 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 350.16B | 1.37% | 4,970,906 | 450.53B |
| 6 | NVS | Novartis AG | 302.17B | 1.68% | 1,181,724 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 258.76B | 0.91% | 3,179,577 | 61.37B |
| 8 | AMGN | Amgen Inc. | 237.52B | 1.29% | 2,114,499 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 232.67B | 0.27% | 1,556,006 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 207.84B | 1.30% | 10,281,928 | 50.34B |
| 11 | ABT | Abbott Laboratories | 201.83B | 2.19% | 10,930,969 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 181.18B | 1.87% | 5,384,310 | 30.46B |
| 13 | PFE | Pfizer Inc. | 159.99B | 1.01% | 37,080,220 | 63.70B |
| 14 | DHR | Danaher Corporation | 153.85B | 1.36% | 3,995,634 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 138.91B | 1.44% | 1,074,796 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 136.88B | 2.35% | 7,932,376 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 133.83B | 1.16% | 2,010,297 | 11.03B |
| 18 | SYK | Stryker Corporation | 126.37B | 0.53% | 3,163,299 | 25.84B |
| 19 | MDT | Medtronic plc | 119.49B | 1.14% | 7,494,494 | 36.36B |
| 20 | CVS | CVS Health Corporation | 118.97B | -0.67% | 5,591,911 | 412.65B |
| 21 | SNY | Sanofi | 110.41B | 1.55% | 1,860,590 | 55.89B |
| 22 | GSK | GSK plc | 104.78B | 0.87% | 2,218,218 | 44.05B |
| 23 | MCK | McKesson Corporation | 100.14B | 2.40% | 1,580,712 | 410.98B |
| 24 | HCA | HCA Healthcare, Inc. | 92.92B | 5.64% | 2,058,051 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 86.86B | 1.07% | 771,535 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 83.28B | 0.90% | 786,840 | 15.53B |
| 27 | CI | The Cigna Group | 73.33B | 1.13% | 2,057,414 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 73.00B | 2.03% | 31,749,406 | 21.00B |
| 29 | ARGX | argenx SE | 65.85B | 0.16% | 377,171 | 5.32B |
| 30 | COR | Cencora, Inc. | 60.69B | 1.06% | 804,403 | 332.77B |
| 31 | MRNA | Moderna, Inc. | 57.94B | 8.86% | 87,205,307 | 2.23B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 57.89B | 0.28% | 1,386,768 | 28.42B |
| 33 | CAH | Cardinal Health, Inc. | 53.38B | 0.46% | 925,062 | 254.25B |
| 34 | BDX | Becton, Dickinson and Company | 52.30B | 2.33% | 1,787,917 | 22.48B |
| 35 | EW | Edwards Lifesciences Corporation | 51.75B | -0.04% | 2,075,074 | 6.51B |
| 36 | NTRA | Natera, Inc. | 47.86B | 2.21% | 1,214,609 | 2.71B |
| 37 | HUM | Humana Inc. | 45.50B | -0.49% | 832,999 | 145.68B |
| 38 | MDLN | Medline Inc. | 45.04B | 5.16% | 6,984,619 | 29.94B |
| 39 | A | Agilent Technologies, Inc. | 44.91B | 1.73% | 2,734,548 | 7.23B |
| 40 | RVMD | Revolution Medicines, Inc. | 44.89B | -1.07% | 2,123,937 | - |
| 41 | IDXX | IDEXX Laboratories, Inc. | 43.88B | 2.03% | 485,741 | 4.55B |
| 42 | HLN | Haleon plc | 43.60B | 1.32% | 7,160,264 | 14.80B |
| 43 | TEVA | Teva Pharmaceutical Industries Limited | 43.51B | 1.44% | 4,300,078 | 17.32B |
| 44 | IQV | IQVIA Holdings Inc. | 42.77B | 1.47% | 1,138,025 | 16.98B |
| 45 | ONC | BeOne Medicines AG | 42.58B | 1.44% | 252,598 | 6.13B |
| 46 | WAT | Waters Corporation | 40.35B | 1.49% | 682,898 | 4.64B |
| 47 | VEEV | Veeva Systems Inc. | 40.27B | -1.05% | 890,044 | 3.32B |
| 48 | ALC | Alcon Inc. | 35.46B | 0.96% | 906,301 | 10.86B |
| 49 | RPRX | Royalty Pharma plc | 35.25B | 1.21% | 2,325,103 | 2.54B |
| 50 | DXCM | DexCom, Inc. | 34.85B | 2.35% | 3,481,269 | 4.97B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 33.80B | 1.03% | 2,247,350 | 21.27B |
| 52 | RMD | ResMed Inc. | 33.40B | 1.35% | 923,960 | 5.65B |
| 53 | ILMN | Illumina, Inc. | 33.13B | 2.89% | 1,916,821 | 4.49B |
| 54 | ZTS | Zoetis Inc. | 32.12B | 3.61% | 5,050,758 | 9.53B |
| 55 | CNC | Centene Corporation | 32.12B | 1.37% | 2,171,197 | 180.30B |
| 56 | BIIB | Biogen Inc. | 32.03B | 1.13% | 722,318 | 10.03B |
| 57 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.61B | 3.02% | 1,902,237 | 4.80B |
| 58 | BNTX | BioNTech SE | 29.28B | 5.12% | 2,960,396 | 3.03B |
| 59 | MTD | Mettler-Toledo International Inc. | 27.96B | 0.14% | 317,419 | 4.13B |
| 60 | INSM | Insmed Incorporated | 27.47B | 0.55% | 1,124,461 | 1.14B |
| 61 | LH | Labcorp Holdings Inc. | 27.28B | 1.06% | 418,217 | 14.35B |
| 62 | DGX | Quest Diagnostics Incorporated | 26.97B | 1.28% | 733,293 | 11.56B |
| 63 | PHG | Koninklijke Philips N.V. | 26.94B | -0.29% | 640,735 | 20.18B |
| 64 | ROIV | Roivant Sciences Ltd. | 26.22B | -1.47% | 6,185,417 | 7.53M |
| 65 | INCY | Incyte Corporation | 25.91B | 0.46% | 1,359,097 | 5.82B |
| 66 | WST | West Pharmaceutical Services, Inc. | 24.85B | -0.20% | 511,125 | 3.33B |
| 67 | STE | STERIS plc | 23.20B | 0.93% | 307,053 | 6.04B |
| 68 | GH | Guardant Health, Inc. | 22.91B | 1.67% | 1,914,022 | 1.18B |
| 69 | THC | Tenet Healthcare Corporation | 22.61B | 3.00% | 818,765 | 21.81B |
| 70 | UTHR | United Therapeutics Corporation | 22.01B | -1.51% | 415,569 | 3.15B |
| 71 | GMAB | Genmab A/S | 20.06B | 0.12% | 2,535,451 | 4.13B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 19.26B | 2.03% | 881,418 | 8.51B |
| 73 | VTRS | Viatris Inc. | 18.75B | 1.24% | 4,712,536 | 14.74B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.33B | 1.32% | 225,881 | 2.78B |
| 75 | ASND | Ascendis Pharma A/S | 16.63B | -0.60% | 363,758 | 1.20B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 16.51B | 2.24% | 516,583 | 4.60B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 15.93B | -1.74% | 1,819,205 | 713.07M |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 15.51B | -0.24% | 1,209,471 | 3.37B |
| 79 | SOLV | Solventum Corporation | 15.25B | 1.08% | 730,537 | 8.31B |
| 80 | COO | The Cooper Companies, Inc. | 14.87B | 0.08% | 1,554,122 | 4.23B |
| 81 | CRL | Charles River Laboratories International, Inc. | 14.09B | 1.28% | 757,551 | 4.00B |
| 82 | RVTY | Revvity, Inc. | 13.92B | 0.50% | 2,289,715 | 2.91B |
| 83 | BAX | Baxter International Inc. | 13.62B | -0.27% | 3,078,414 | 11.47B |
| 84 | EXEL | Exelixis, Inc. | 13.40B | 0.73% | 1,949,642 | 2.44B |
| 85 | ICLR | ICON Public Limited Company | 13.29B | -1.17% | 391,169 | 8.29B |
| 86 | CORT | Corcept Therapeutics Incorporated | 13.22B | 0.99% | 656,311 | 830.81M |
| 87 | TEM | Tempus AI, Inc. | 13.12B | 9.06% | 15,932,475 | 1.43B |
| 88 | BMRN | BioMarin Pharmaceutical Inc. | 12.91B | -1.45% | 1,166,102 | 3.41B |
| 89 | PEN | Penumbra, Inc. | 12.81B | 0.44% | 147,195 | 1.50B |
| 90 | FMS | Fresenius Medical Care AG | 12.42B | - | 826,622 | 22.19B |
| 91 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.30B | -0.41% | 1,089,754 | 669.50M |
| 92 | HALO | Halozyme Therapeutics, Inc. | 12.28B | 1.93% | 1,173,961 | 1.66B |
| 93 | BTSG | BrightSpring Health Services, Inc. | 12.26B | -1.11% | 1,523,698 | 14.37B |
| 94 | SNN | Smith & Nephew plc | 12.26B | 0.76% | 790,075 | 6.30B |
| 95 | ELAN | Elanco Animal Health Incorporated | 11.98B | 1.74% | 4,756,084 | 5.02B |
| 96 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.94B | -0.45% | 179,830 | 1.28B |
| 97 | EHC | Encompass Health Corporation | 11.87B | -0.50% | 542,394 | 6.21B |
| 98 | GMED | Globus Medical, Inc. | 11.67B | 1.45% | 930,800 | 3.14B |
| 99 | ALGN | Align Technology, Inc. | 11.55B | 2.27% | 793,711 | 4.14B |
| 100 | TECH | Bio-Techne Corporation | 11.34B | 0.06% | 3,957,631 | 1.22B |
| 101 | ABVX | ABIVAX Société Anonyme | 11.12B | -2.75% | 986,918 | 5.67M |
| 102 | DVA | DaVita Inc. | 11.08B | -0.81% | 472,893 | 14.01B |
| 103 | GKOS | Glaukos Corporation | 10.90B | - | 348,104 | 612.84M |
| 104 | AXSM | Axsome Therapeutics, Inc. | 10.88B | -0.12% | 734,780 | 776.57M |
| 105 | CYTK | Cytokinetics, Incorporated | 10.68B | -0.44% | 1,521,131 | 67.67M |
| 106 | SMMT | Summit Therapeutics Inc. | 10.50B | 5.87% | 7,073,277 | - |
| 107 | PRAX | Praxis Precision Medicines, Inc. | 10.50B | 3.12% | 413,316 | 7.46M |
| 108 | UHS | Universal Health Services, Inc. | 10.45B | 2.54% | 446,795 | 18.11B |
| 109 | MOH | Molina Healthcare, Inc. | 10.43B | 1.70% | 471,949 | 42.47B |
| 110 | ENSG | The Ensign Group, Inc. | 10.37B | -0.21% | 280,971 | 5.49B |
| 111 | PODD | Insulet Corporation | 10.28B | 0.88% | 903,573 | 3.05B |
| 112 | KRYS | Krystal Biotech, Inc. | 10.26B | 2.84% | 407,782 | 440.48M |
| 113 | RDY | Dr. Reddy's Laboratories Limited | 10.23B | 0.58% | 1,745,877 | 3.50B |
| 114 | RGEN | Repligen Corporation | 10.22B | 0.47% | 1,014,978 | 785.10M |
| 115 | APGE | Apogee Therapeutics, Inc. | 10.16B | - | 948,282 | - |
| 116 | BIO | Bio-Rad Laboratories, Inc. | 10.16B | 0.95% | 341,174 | 2.59B |
| 117 | PTGX | Protagonist Therapeutics, Inc. | 9.99B | 2.41% | 402,517 | 281.99M |
| 118 | KYMR | Kymera Therapeutics, Inc. | 9.96B | -1.40% | 503,426 | 105.00M |
| 119 | IONS | Ionis Pharmaceuticals, Inc. | 9.93B | 1.67% | 2,723,529 | 874.09M |
| 120 | OSCR | Oscar Health, Inc. | 9.88B | 1.49% | 5,357,068 | 15.32B |
| 121 | HSIC | Henry Schein, Inc. | 9.86B | 0.05% | 758,814 | 13.60B |
| 122 | AVTR | Avantor, Inc. | 9.78B | 1.47% | 5,207,410 | 6.56B |
| 123 | SYRE | Spyre Therapeutics, Inc. | 9.39B | -1.21% | 1,014,893 | - |
| 124 | PCVX | Vaxcyte, Inc. | 9.32B | 2.09% | 1,141,427 | - |
| 125 | IMVT | Immunovant, Inc. | 9.16B | 0.05% | 846,584 | - |
| 126 | TWST | Twist Bioscience Corporation | 9.13B | 6.79% | 1,794,603 | 431.80M |
| 127 | QGEN | Qiagen N.V. | 9.11B | -1.85% | 2,897,189 | 2.10B |
| 128 | BRKR | Bruker Corporation | 9.07B | -0.60% | 3,199,934 | 3.50B |
| 129 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.98B | - | 2,016,045 | 42.16M |
| 130 | HQY | HealthEquity, Inc. | 8.81B | 1.09% | 608,556 | 1.34B |
| 131 | ATR | AptarGroup, Inc. | 8.57B | 1.38% | 400,496 | 3.93B |
| 132 | TXG | 10x Genomics, Inc. | 8.48B | 1.96% | 2,713,634 | 616.91M |
| 133 | IBRX | ImmunityBio, Inc. | 8.26B | -0.64% | 7,591,970 | 165.79M |
| 134 | ALKS | Alkermes plc | 8.11B | 0.65% | 939,633 | 1.67B |
| 135 | HIMS | Hims & Hers Health, Inc. | 7.88B | 6.03% | 14,687,351 | 2.58B |
| 136 | TGTX | TG Therapeutics, Inc. | 7.70B | 7.34% | 5,552,406 | 799.54M |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.57B | 0.99% | 523,136 | 239.92M |
| 138 | CAI | Caris Life Sciences, Inc. | 7.42B | 6.88% | 6,388,487 | 989.61M |
| 139 | ORKA | Oruka Therapeutics, Inc. | 7.15B | 2.96% | 935,776 | - |
| 140 | HNGE | Hinge Health, Inc. | 7.14B | 3.27% | 1,305,175 | 720.06M |
| 141 | CGON | CG Oncology, Inc. | 7.07B | 2.83% | 701,639 | 6.23M |
| 142 | CHE | Chemed Corporation | 7.04B | 1.06% | 98,970 | 2.60B |
| 143 | PACS | PACS Group, Inc. | 7.01B | 1.54% | 691,948 | 5.55B |
| 144 | GRFS | Grifols, S.A. | 6.97B | 0.13% | 218,131 | 8.48B |
| 145 | SRRK | Scholar Rock Holding Corporation | 6.88B | 2.26% | 1,156,414 | - |
| 146 | LNTH | Lantheus Holdings, Inc. | 6.53B | -0.27% | 1,076,093 | 1.56B |
| 147 | BLTE | Belite Bio, Inc | 6.49B | -0.54% | 111,156 | - |
| 148 | COGT | Cogent Biosciences, Inc. | 6.38B | 4.02% | 2,515,728 | - |
| 149 | MIRM | Mirum Pharmaceuticals, Inc. | 6.25B | -0.78% | 731,681 | 618.07M |
| 150 | DNTH | Dianthus Therapeutics, Inc. | 6.21B | 1.45% | 730,865 | 1.90M |
| 151 | TVTX | Travere Therapeutics, Inc. | 6.19B | 1.94% | 1,624,893 | 591.33M |
| 152 | STVN | Stevanato Group S.p.A. | 6.17B | 1.12% | 252,623 | 1.40B |
| 153 | ERAS | Erasca, Inc. | 6.17B | 3.22% | 2,445,399 | - |
| 154 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.17B | 0.71% | 269,880 | 840.85M |
| 155 | BLCO | Bausch + Lomb Corporation | 6.16B | 0.23% | 183,488 | 5.32B |
| 156 | LQDA | Liquidia Corporation | 6.14B | -3.42% | 1,698,531 | 450.91M |
| 157 | RDNT | RadNet, Inc. | 6.05B | -0.30% | 644,046 | 2.27B |
| 158 | DFTX | Definium Therapeutics, Inc. | 6.03B | -1.08% | 1,354,284 | - |
| 159 | XENE | Xenon Pharmaceuticals Inc. | 5.88B | 1.74% | 783,711 | 7.50M |
| 160 | TFX | Teleflex Incorporated | 5.88B | 2.87% | 641,967 | 2.25B |
| 161 | PTCT | PTC Therapeutics, Inc. | 5.83B | -0.99% | 674,736 | 1.01B |
| 162 | CRSP | CRISPR Therapeutics AG | 5.75B | 2.37% | 2,452,009 | 13.39M |
| 163 | MMED | MiniMed Group, Inc. | 5.74B | 1.34% | 1,119,112 | 3.10B |
| 164 | AMRX | Amneal Pharmaceuticals, Inc. | 5.72B | 0.06% | 1,365,019 | 3.12B |
| 165 | LGND | Ligand Pharmaceuticals Incorporated | 5.71B | -0.38% | 152,535 | 290.54M |
| 166 | SHC | Sotera Health Company | 5.58B | 1.82% | 2,350,203 | 1.22B |
| 167 | MMSI | Merit Medical Systems, Inc. | 5.42B | 0.56% | 401,797 | 1.58B |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 5.08B | 1.58% | 1,093,500 | 1.14B |
| 169 | HAE | Haemonetics Corporation | 4.95B | 0.54% | 582,104 | 1.35B |
| 170 | DYN | Dyne Therapeutics, Inc. | 4.87B | 0.46% | 1,181,539 | - |
| 171 | PBLS | Parabilis Medicines, Inc. | 4.86B | -0.56% | 354,579 | 148.00K |
| 172 | EWTX | Edgewise Therapeutics, Inc. | 4.80B | 2.06% | 1,249,637 | - |
| 173 | WAY | Waystar Holding Corp. | 4.80B | 0.68% | 2,542,717 | 1.21B |
| 174 | LFST | LifeStance Health Group, Inc. | 4.76B | -1.42% | 2,616,845 | 1.58B |
| 175 | CELC | Celcuity Inc. | 4.58B | 3.27% | 889,294 | - |
| 176 | ICUI | ICU Medical, Inc. | 4.57B | 0.17% | 182,318 | 2.16B |
| 177 | DOCS | Doximity, Inc. | 4.51B | -2.35% | 2,676,721 | 655.57M |
| 178 | BLLN | BillionToOne, Inc. | 4.48B | -0.25% | 588,617 | 397.41M |
| 179 | CON | Concentra Group Holdings Parent, Inc. | 4.46B | 0.55% | 585,964 | 2.29B |
| 180 | ELVN | Enliven Therapeutics, Inc. | 4.38B | 1.53% | 596,337 | - |
| 181 | NVST | Envista Holdings Corporation | 4.37B | 1.00% | 1,590,597 | 2.86B |
| 182 | INDV | Indivior Pharmaceuticals, Inc. | 4.35B | -2.41% | 2,496,688 | 1.33B |
| 183 | LIVN | LivaNova PLC | 4.34B | 0.68% | 440,214 | 1.47B |
| 184 | HTFL | HeartFlow, Inc. | 4.33B | 6.30% | 2,462,209 | 212.07M |
| 185 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.31B | -2.52% | 4,641,624 | -665.00K |
| 186 | MANE | Veradermics, Incorporated | 4.30B | -2.37% | 393,616 | - |
| 187 | RLAY | Relay Therapeutics, Inc. | 4.26B | -1.32% | 2,965,763 | 10.35M |
| 188 | ITGR | Integer Holdings Corporation | 4.26B | -0.01% | 612,795 | 1.84B |
| 189 | IRTC | iRhythm Holdings, Inc. | 4.24B | 0.42% | 451,631 | 825.34M |
| 190 | LEGN | Legend Biotech Corporation | 4.23B | 2.63% | 1,422,959 | 1.27B |
| 191 | ADPT | Adaptive Biotechnologies Corporation | 4.15B | 2.16% | 1,816,798 | 308.08M |
| 192 | TNGX | Tango Therapeutics, Inc. | 4.03B | 1.57% | 2,146,586 | 53.81M |
| 193 | DNLI | Denali Therapeutics Inc. | 3.98B | -0.12% | 680,924 | 3.60M |
| 194 | VKTX | Viking Therapeutics, Inc. | 3.95B | -1.37% | 1,501,159 | - |
| 195 | RCUS | Arcus Biosciences, Inc. | 3.86B | 2.78% | 890,728 | 117.00M |
| 196 | IDYA | IDEAYA Biosciences, Inc. | 3.83B | 1.43% | 860,569 | 234.13M |
| 197 | TLX | Telix Pharmaceuticals Limited | 3.80B | -8.78% | 299,600 | 890.79M |
| 198 | IOVA | Iovance Biotherapeutics, Inc. | 3.76B | -7.79% | 27,782,335 | 324.97M |
| 199 | ABCL | AbCellera Biologics Inc. | 3.67B | -2.16% | 4,543,126 | 66.17M |
| 200 | NHC | National HealthCare Corporation | 3.66B | -1.41% | 74,489 | 1.56B |
| 201 | OGN | Organon & Co. | 3.61B | 0.07% | 1,486,267 | 6.13B |
| 202 | PLSE | Pulse Biosciences, Inc. | 3.60B | 5.37% | 411,739 | 1.19M |
| 203 | GRAL | GRAIL, Inc. | 3.55B | 2.01% | 604,487 | 165.26M |
| 204 | OPCH | Option Care Health, Inc. | 3.55B | 0.89% | 1,599,633 | 5.69B |
| 205 | GPCR | Structure Therapeutics Inc. | 3.50B | -2.83% | 592,278 | - |
| 206 | VCYT | Veracyte, Inc. | 3.40B | 1.24% | 1,005,479 | 561.90M |
| 207 | WRBY | Warby Parker Inc. | 3.39B | -0.07% | 1,648,081 | 911.61M |
| 208 | QURE | uniQure N.V. | 3.36B | -1.06% | 673,833 | 18.67M |
| 209 | NAMS | NewAmsterdam Pharma Company N.V. | 3.33B | 0.32% | 525,427 | 7.12M |
| 210 | TMDX | TransMedics Group, Inc. | 3.29B | 4.31% | 626,767 | 668.47M |
| 211 | IMNM | Immunome, Inc. | 3.24B | 1.57% | 846,147 | 4.02M |
| 212 | MBX | MBX Biosciences, Inc. | 3.19B | -0.03% | 466,325 | - |
| 213 | TARS | Tarsus Pharmaceuticals, Inc. | 3.19B | 1.69% | 636,334 | 606.33M |
| 214 | CLDX | Celldex Therapeutics, Inc. | 3.17B | 1.10% | 837,587 | 158.00K |
| 215 | ARQT | Arcutis Biotherapeutics, Inc. | 3.15B | -1.07% | 2,159,269 | 463.98M |
| 216 | ALMS | Alumis Inc. | 3.13B | 5.73% | 934,650 | 7.40M |
| 217 | SLS | SELLAS Life Sciences Group, Inc. | 3.12B | 15.37% | 15,210,456 | - |
| 218 | IRON | Disc Medicine, Inc. | 3.06B | 1.23% | 370,352 | - |
| 219 | BEAM | Beam Therapeutics Inc. | 2.97B | 4.83% | 2,153,291 | 156.04M |
| 220 | ZLAB | Zai Lab Limited | 2.92B | -0.04% | 1,001,570 | 449.61M |
| 221 | AVAH | Aveanna Healthcare Holdings Inc. | 2.87B | 1.46% | 8,415,662 | 2.60B |
| 222 | BKD | Brookdale Senior Living Inc. | 2.82B | -0.08% | 4,545,014 | 2.93B |
| 223 | NRIX | Nurix Therapeutics, Inc. | 2.77B | -1.22% | 1,485,856 | 36.77M |
| 224 | VRDN | Viridian Therapeutics, Inc. | 2.75B | -0.86% | 906,073 | 71.13M |
| 225 | ATAI | AtaiBeckley Inc. | 2.74B | -0.54% | 4,307,465 | 4.47M |
| 226 | ALHC | Alignment Healthcare, Inc. | 2.73B | 1.78% | 2,220,860 | 4.58B |
| 227 | AXGN | Axogen, Inc. | 2.71B | 8.53% | 1,779,619 | 251.17M |
| 228 | PRVA | Privia Health Group, Inc. | 2.70B | -0.33% | 914,451 | 2.36B |
| 229 | SUPN | Supernus Pharmaceuticals, Inc. | 2.67B | -3.37% | 748,892 | 830.44M |
| 230 | RGC | Regencell Bioscience Holdings Limited | 2.63B | -2.57% | 153,160 | - |
| 231 | NEOG | Neogen Corporation | 2.61B | 1.01% | 1,212,550 | 870.40M |
| 232 | WGS | GeneDx Holdings Corp. | 2.60B | 5.47% | 555,045 | 454.43M |
| 233 | ACHC | Acadia Healthcare Company, Inc. | 2.59B | 3.15% | 1,112,169 | 3.37B |
| 234 | PGEN | Precigen, Inc. | 2.58B | -3.23% | 4,406,123 | 85.72M |
| 235 | TRVI | Trevi Therapeutics, Inc. | 2.56B | -1.59% | 954,791 | - |
| 236 | PHVS | Pharvaris N.V. | 2.55B | -0.33% | 515,366 | - |
| 237 | BFLY | Butterfly Network, Inc. | 2.54B | 4.14% | 5,168,119 | 112.14M |
| 238 | RARE | Ultragenyx Pharmaceutical Inc. | 2.54B | 2.01% | 2,392,278 | 717.00M |
| 239 | NKTR | Nektar Therapeutics | 2.53B | -0.68% | 614,080 | 54.59M |
| 240 | CDNA | CareDx, Inc. | 2.51B | 3.45% | 1,159,804 | 458.09M |
| 241 | ATRC | AtriCure, Inc. | 2.49B | 3.14% | 421,110 | 569.62M |
| 242 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.44B | -1.14% | 2,492,708 | 940.61M |
| 243 | OCUL | Ocular Therapeutix, Inc. | 2.43B | -0.09% | 3,051,266 | 52.06M |
| 244 | NUVB | Nuvation Bio Inc. | 2.43B | 1.46% | 6,042,880 | 169.90M |
| 245 | PBH | Prestige Consumer Healthcare Inc. | 2.43B | 1.56% | 264,509 | 1.10B |
| 246 | BHC | Bausch Health Companies Inc. | 2.41B | -5.43% | 3,720,008 | 10.85B |
| 247 | KOD | Kodiak Sciences Inc. | 2.40B | -3.79% | 508,992 | - |
| 248 | GRDN | Guardian Pharmacy Services, Inc. | 2.40B | 1.20% | 222,972 | 1.46B |
| 249 | UFPT | UFP Technologies, Inc. | 2.39B | 1.60% | 142,830 | 631.64M |
| 250 | ALMR | Alamar Biosciences, Inc. | 2.38B | -1.15% | 212,394 | 100.42M |
| 251 | VERA | Vera Therapeutics, Inc. | 2.33B | 3.25% | 1,288,053 | - |
| 252 | RAPP | Rapport Therapeutics, Inc. | 2.31B | 0.82% | 140,868 | 20.00M |
| 253 | COAG | Hemab Therapeutics Holdings, Inc. | 2.30B | 1.99% | 391,756 | - |
| 254 | URGN | UroGen Pharma Ltd. | 2.29B | 0.13% | 755,445 | 188.73M |
| 255 | MLYS | Mineralys Therapeutics, Inc. | 2.27B | -0.39% | 699,828 | - |
| 256 | NBTX | Nanobiotix S.A. | 2.25B | -0.30% | 74,312 | 38.27M |
| 257 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.24B | 4.22% | 8,555,804 | 208.78M |
| 258 | KLRA | Kailera Therapeutics, Inc. | 2.23B | -1.66% | 436,806 | - |
| 259 | HRMY | Harmony Biosciences Holdings, Inc. | 2.22B | 0.21% | 380,014 | 959.90M |
| 260 | AUPH | Aurinia Pharmaceuticals Inc. | 2.22B | -3.59% | 1,248,726 | 311.51M |
| 261 | ADUS | Addus HomeCare Corporation | 2.21B | 0.22% | 264,488 | 1.48B |
| 262 | CLOV | Clover Health Investments, Corp. | 2.20B | 1.22% | 2,713,992 | 2.48B |
| 263 | ADMA | ADMA Biologics, Inc. | 2.20B | 0.82% | 1,475,942 | 512.28M |
| 264 | MESO | Mesoblast Limited | 2.20B | -2.47% | 164,709 | 65.38M |
| 265 | VCEL | Vericel Corporation | 2.19B | 1.35% | 647,127 | 306.30M |
| 266 | NEO | NeoGenomics, Inc. | 2.18B | 2.72% | 1,139,749 | 766.30M |
| 267 | HCM | HUTCHMED (China) Limited | 2.18B | 0.56% | 64,398 | 549.12M |
| 268 | XRAY | DENTSPLY SIRONA Inc. | 2.18B | 1.30% | 3,311,578 | 3.64B |
| 269 | ESTA | Establishment Labs Holdings Inc. | 2.17B | 1.61% | 588,680 | 245.82M |
| 270 | TRLV | Trulieve Cannabis Corp. | 2.14B | 8.29% | 1,611,644 | 1.14B |
| 271 | MD | Pediatrix Medical Group, Inc. | 2.11B | 1.33% | 716,600 | 1.95B |
| 272 | ZBIO | Zenas BioPharma, Inc. | 2.10B | 2.12% | 808,682 | 1.00M |
| 273 | BHVN | Biohaven Ltd. | 2.09B | 2.59% | 1,782,909 | - |
| 274 | STOK | Stoke Therapeutics, Inc. | 2.08B | 2.83% | 1,274,382 | 27.59M |
| 275 | GENB | Generate Biomedicines, Inc. | 2.07B | 0.81% | 830,793 | 26.48M |
| 276 | XNCR | Xencor, Inc. | 2.07B | 2.96% | 753,067 | 104.97M |
| 277 | PVLA | Palvella Therapeutics, Inc. | 2.05B | -0.38% | 161,866 | - |
| 278 | ZYME | Zymeworks Inc. | 2.03B | 7.90% | 835,715 | 37.13M |
| 279 | ASTH | Astrana Health, Inc. | 2.01B | 1.57% | 395,105 | 3.84B |
| 280 | NVCR | NovoCure Limited | 1.99B | -3.77% | 1,403,798 | 699.19M |
| 281 | SRPT | Sarepta Therapeutics, Inc. | 1.98B | -2.24% | 1,674,554 | 1.97B |
| 282 | TSHA | Taysha Gene Therapies, Inc. | 1.98B | -0.33% | 2,830,960 | 5.49M |
| 283 | PRGO | Perrigo Company plc | 1.98B | 4.01% | 1,947,638 | 4.14B |
| 284 | AGIO | Agios Pharmaceuticals, Inc. | 1.98B | -1.61% | 577,551 | 98.34M |
| 285 | PGNY | Progyny, Inc. | 1.97B | -1.19% | 1,076,774 | 1.31B |
| 286 | KARD | Kardigan, Inc. | 1.97B | 3.75% | 159,546 | - |
| 287 | PSNL | Personalis, Inc. | 1.96B | 8.89% | 7,997,472 | 69.67M |
| 288 | GHRS | GH Research PLC | 1.94B | -1.22% | 141,702 | - |
| 289 | FBRX | Forte Biosciences, Inc. | 1.94B | 0.04% | 2,011,904 | - |
| 290 | LKFT | Lakefront Biotherapeutics NV | 1.91B | 1.87% | 264,375 | 1.13B |
| 291 | DMRA | Damora Therapeutics, Inc. | 1.90B | 1.68% | 159,903 | - |
| 292 | IMCR | Immunocore Holdings plc | 1.90B | 1.65% | 329,451 | 430.78M |
| 293 | SGRY | Surgery Partners, Inc. | 1.88B | 4.16% | 3,226,158 | 3.37B |
| 294 | RXRX | Recursion Pharmaceuticals, Inc. | 1.88B | 4.79% | 22,864,503 | 54.86M |
| 295 | SNDA | Sonida Senior Living, Inc. | 1.87B | 0.74% | 253,005 | 481.07M |
| 296 | LMAT | LeMaitre Vascular, Inc. | 1.87B | -0.56% | 419,886 | 262.43M |
| 297 | SEPN | Septerna, Inc. | 1.87B | -1.94% | 289,806 | 98.88M |
| 298 | CMPS | COMPASS Pathways plc | 1.85B | -3.55% | 1,813,873 | - |
| 299 | BLFS | BioLife Solutions, Inc. | 1.81B | 0.35% | 750,363 | 106.69M |
| 300 | ETON | Eton Pharmaceuticals, Inc. | 1.81B | 5.94% | 640,054 | 105.60M |
| 301 | INSP | Inspire Medical Systems, Inc. | 1.80B | 1.78% | 330,413 | 898.74M |
| 302 | NTLA | Intellia Therapeutics, Inc. | 1.80B | 3.22% | 3,345,931 | 59.51M |
| 303 | BRVE | Braveheart Bio, Inc. | 1.77B | 0.58% | 130,487 | - |
| 304 | SNDX | Syndax Pharmaceuticals, Inc. | 1.75B | -0.51% | 1,695,906 | 252.25M |
| 305 | FTRE | Fortrea Holdings Inc. | 1.75B | 1.10% | 864,119 | 2.68B |
| 306 | ANAB | AnaptysBio, Inc. | 1.71B | 1.85% | 318,372 | 232.39M |
| 307 | AVLN | Avalyn Pharma Inc. | 1.70B | 3.34% | 159,499 | - |
| 308 | VIR | Vir Biotechnology, Inc. | 1.65B | 6.19% | 1,756,367 | 303.23M |
| 309 | ABSI | Absci Corporation | 1.64B | 2.91% | 2,331,508 | 1.56M |
| 310 | AZTA | Azenta, Inc. | 1.64B | 2.44% | 647,089 | 613.81M |
| 311 | MAZE | Maze Therapeutics, Inc. | 1.63B | 1.73% | 280,573 | 20.00M |
| 312 | OMCL | Omnicell, Inc. | 1.62B | 0.23% | 777,064 | 1.25B |
| 313 | AGL | agilon health, inc. | 1.62B | 4.15% | 277,388 | 5.92B |
| 314 | ANIP | ANI Pharmaceuticals, Inc. | 1.61B | -2.55% | 379,117 | 978.38M |
| 315 | XERS | Xeris Biopharma Holdings, Inc. | 1.59B | 1.16% | 1,562,896 | 335.41M |
| 316 | KMTS | Kestra Medical Technologies, Ltd. | 1.58B | -0.99% | 510,787 | 95.13M |
| 317 | BCAX | Bicara Therapeutics Inc. | 1.58B | -2.01% | 496,340 | - |
| 318 | ALVO | Alvotech | 1.58B | 3.75% | 2,268,900 | 494.61M |
| 319 | HCSG | Healthcare Services Group, Inc. | 1.56B | -1.00% | 457,192 | 1.86B |
| 320 | FRNM | Freenome, Inc. | 1.56B | 2.22% | 735,008 | 34.24M |
| 321 | TYRA | Tyra Biosciences, Inc. | 1.55B | 1.40% | 493,596 | - |
| 322 | APMD | Apnimed, Inc. | 1.55B | -1.82% | 245,229 | 120.15M |
| 323 | TNDM | Tandem Diabetes Care, Inc. | 1.55B | -1.11% | 1,636,303 | 1.04B |
| 324 | ARDT | Ardent Health, Inc. | 1.55B | 4.87% | 175,490 | 6.41B |
| 325 | AAPG | Ascentage Pharma Group International | 1.54B | -1.85% | 1,812 | 94.61M |
| 326 | TRAX | First Tracks Biotherapeutics, Inc. | 1.54B | 2.89% | 527,979 | - |
| 327 | LBRX | LB Pharmaceuticals Inc | 1.54B | 0.83% | 225,825 | - |
| 328 | HROW | Harrow, Inc. | 1.54B | -2.64% | 466,400 | 275.59M |
| 329 | CNMD | CONMED Corporation | 1.53B | -0.60% | 183,414 | 1.37B |
| 330 | INBX | Inhibrx Biosciences, Inc. | 1.53B | 4.52% | 220,742 | 1.30M |
| 331 | INVA | Innoviva, Inc. | 1.52B | 0.33% | 499,377 | 440.00M |
| 332 | SLBT | SL Science Holding Limited | 1.51B | -2.21% | 28,476 | 3.27M |
| 333 | ENOV | Enovis Corporation | 1.50B | -0.46% | 451,566 | 2.30B |
| 334 | INNV | InnovAge Holding Corp. | 1.49B | 2.24% | 366,061 | 949.17M |
| 335 | NVAX | Novavax, Inc. | 1.47B | 6.18% | 9,562,757 | 413.80M |
| 336 | SDGR | Schrödinger, Inc. | 1.47B | 0.66% | 1,094,256 | 259.04M |
| 337 | PAHC | Phibro Animal Health Corporation | 1.47B | 3.24% | 324,367 | 1.50B |
| 338 | ORIC | ORIC Pharmaceuticals, Inc. | 1.47B | 2.31% | 970,282 | - |
| 339 | ATEC | Alphatec Holdings, Inc. | 1.46B | 2.05% | 1,452,182 | 815.05M |
| 340 | OMDA | Omada Health, Inc. | 1.46B | 0.76% | 482,836 | 309.76M |
| 341 | AVBP | ArriVent BioPharma, Inc. | 1.44B | -0.21% | 304,809 | - |
| 342 | SVRA | Savara Inc. | 1.42B | 1.82% | 3,035,161 | - |
| 343 | LTGO | Latigo Biotherapeutics, Inc. | 1.41B | 4.53% | 197,197 | - |
| 344 | CGEM | Cullinan Therapeutics, Inc. | 1.40B | 1.40% | 758,081 | - |
| 345 | OMER | Omeros Corporation | 1.39B | 3.44% | 2,582,426 | 38.42M |
| 346 | REPL | Replimune Group, Inc. | 1.39B | 5.12% | 2,969,262 | - |
| 347 | VOR | Vor Biopharma Inc. | 1.38B | 1.28% | 618,061 | - |
| 348 | DRTS | Alpha Tau Medical Ltd. | 1.38B | 3.90% | 626,150 | - |
| 349 | MGTX | MeiraGTx Holdings plc | 1.38B | -1.38% | 635,483 | 397.50M |
| 350 | AORT | Artivion, Inc. | 1.37B | 0.36% | 383,320 | 471.47M |
| 351 | PNTG | The Pennant Group, Inc. | 1.36B | -0.31% | 341,276 | 1.10B |
| 352 | JBIO | Jade Biosciences, Inc. | 1.36B | 0.52% | 571,847 | - |
| 353 | ANRO | Alto Neuroscience, Inc. | 1.35B | 0.09% | 237,168 | - |
| 354 | MLTX | MoonLake Immunotherapeutics | 1.34B | -0.69% | 1,350,884 | - |
| 355 | AKTS | Aktis Oncology, Inc. | 1.34B | 0.29% | 226,257 | 10.06M |
| 356 | AMN | AMN Healthcare Services, Inc. | 1.33B | -0.95% | 445,328 | 3.43B |
| 357 | MNKD | MannKind Corporation | 1.33B | -2.58% | 3,204,512 | 393.63M |
| 358 | IART | Integra LifeSciences Holdings Corporation | 1.30B | 0.90% | 431,477 | 1.65B |
| 359 | SPTX | Seaport Therapeutics, Inc. | 1.30B | 1.14% | 83,149 | - |
| 360 | CERT | Certara, Inc. | 1.29B | -3.44% | 2,044,460 | 421.75M |
| 361 | NUTX | Nutex Health Inc. | 1.27B | -1.43% | 114,808 | 846.72M |
| 362 | ODTX | Odyssey Therapeutics, Inc. | 1.26B | 6.97% | 181,208 | 99.00K |
| 363 | PRCT | PROCEPT BioRobotics Corporation | 1.24B | 4.58% | 821,768 | 337.34M |
| 364 | IMTX | Immatics N.V. | 1.22B | 4.44% | 611,169 | 47.65M |
| 365 | GLUE | Monte Rosa Therapeutics, Inc. | 1.22B | -3.25% | 969,158 | 28.73M |
| 366 | CRVS | Corvus Pharmaceuticals, Inc. | 1.22B | 0.91% | 473,672 | - |
| 367 | BVS | Bioventus Inc. | 1.21B | 0.35% | 748,055 | 581.85M |
| 368 | LMRI | Lumexa Imaging Holdings, Inc. | 1.19B | 6.34% | 487,233 | 1.04B |
| 369 | CRON | Cronos Group Inc. | 1.19B | 2.80% | 1,099,113 | 179.09M |
| 370 | GDRX | GoodRx Holdings, Inc. | 1.18B | -3.09% | 1,746,443 | 785.23M |
| 371 | SANA | Sana Biotechnology, Inc. | 1.17B | 4.55% | 2,923,553 | - |
| 372 | USPH | U.S. Physical Therapy, Inc. | 1.17B | 0.27% | 123,973 | 804.27M |
| 373 | TDOC | Teladoc Health, Inc. | 1.16B | -1.54% | 2,772,153 | 2.49B |
| 374 | STAA | STAAR Surgical Company | 1.16B | 0.30% | 559,939 | 339.59M |
| 375 | IRMD | IRADIMED CORPORATION | 1.12B | 1.35% | 76,178 | 86.34M |
| 376 | IVA | Inventiva S.A. | 1.11B | 0.65% | 461,395 | 7.94M |
| 377 | OPK | OPKO Health, Inc. | 1.10B | 1.37% | 2,659,361 | 587.90M |
| 378 | AVTX | Avalo Therapeutics, Inc. | 1.06B | 0.05% | 569,829 | 59.00K |
| 379 | JANX | Janux Therapeutics, Inc. | 1.06B | 0.64% | 520,030 | 24.00M |
| 380 | KURA | Kura Oncology, Inc. | 1.06B | 1.54% | 2,025,795 | 77.23M |
| 381 | GMRS | GMR Solutions Inc. | 1.05B | -4.67% | 669,368 | 5.88B |
| 382 | CSTL | Castle Biosciences, Inc. | 1.04B | 3.86% | 573,436 | 357.28M |
| 383 | WVE | Wave Life Sciences, Inc. | 1.04B | 0.76% | 2,721,869 | 65.37M |
| 384 | ABUS | Arbutus Biopharma Corporation | 1.03B | 9.22% | 16,697,676 | 181.72M |
| 385 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.02B | 5.50% | 3,193,889 | 41.47M |
| 386 | QDEL | QuidelOrtho Corporation | 1.01B | -0.74% | 2,022,148 | 2.67B |
| 387 | CADL | Candel Therapeutics, Inc. | 1.00B | 6.32% | 1,222,189 | - |
| 388 | SLDB | Solid Biosciences Inc. | 997.19M | 2.20% | 790,346 | - |
| 389 | CLYM | Climb Bio, Inc. | 992.50M | 1.53% | 957,403 | - |
| 390 | PCRX | Pacira BioSciences, Inc. | 983.39M | 3.52% | 348,439 | 746.16M |
| 391 | IMMX | Immix Biopharma, Inc. | 977.23M | 3.80% | 1,510,571 | - |
| 392 | GERN | Geron Corporation | 976.56M | -1.94% | 4,433,149 | 204.56M |
| 393 | ARDX | Ardelyx, Inc. | 969.34M | -0.26% | 2,878,948 | 450.89M |
| 394 | ANNX | Annexon, Inc. | 961.17M | -2.12% | 1,428,380 | - |
| 395 | ACRS | Aclaris Therapeutics, Inc. | 943.54M | 1.26% | 2,208,315 | 8.22M |
| 396 | DSGN | Design Therapeutics, Inc. | 938.10M | -3.66% | 551,765 | - |
| 397 | OLMA | Olema Pharmaceuticals, Inc. | 935.35M | -1.93% | 748,501 | - |
| 398 | CBLL | CeriBell, Inc. | 928.75M | -0.45% | 292,625 | 101.96M |
| 399 | GLAS | Glass House Brands Inc. | 922.63M | 2.84% | 215,154 | 164.83M |
| 400 | AMPH | Amphastar Pharmaceuticals, Inc. | 918.82M | -0.37% | 376,557 | 730.02M |
| 401 | ATTO | Attovia Therapeutics, Inc. | 895.00M | 2.92% | 362,155 | 1.35M |
| 402 | SIBN | SI-BONE, Inc. | 894.58M | 2.46% | 1,290,250 | 213.60M |
| 403 | SGP | SpyGlass Pharma, Inc. | 886.71M | 1.07% | 52,271 | - |
| 404 | TBPH | Theravance Biopharma, Inc. | 883.14M | 0.35% | 739,343 | 104.31M |
| 405 | COLL | Collegium Pharmaceutical, Inc. | 882.58M | -1.56% | 704,929 | 808.21M |
| 406 | ANL | Adlai Nortye Ltd. | 882.25M | -0.15% | 103,050 | 18.06M |
| 407 | AVR | Anteris Technologies Global Corp. | 875.18M | -2.92% | 566,646 | 2.24M |
| 408 | FDMT | 4D Molecular Therapeutics, Inc. | 874.52M | -1.68% | 921,167 | 92.01M |
| 409 | INMD | InMode Ltd. | 865.66M | 0.94% | 304,395 | 374.63M |
| 410 | DBVT | DBV Technologies S.A. | 862.94M | 2.18% | 124,583 | 5.04M |
| 411 | OBX | Obsidian Therapeutics, Inc. | 862.19M | -1.44% | 1,449,276 | - |
| 412 | RIGL | Rigel Pharmaceuticals, Inc. | 857.22M | 1.41% | 322,084 | 276.79M |
| 413 | BBNX | Beta Bionics, Inc. | 857.05M | -2.21% | 496,470 | 119.01M |
| 414 | HSTM | HealthStream, Inc. | 844.16M | 0.98% | 374,482 | 321.12M |
| 415 | PHAR | Pharming Group N.V. | 839.49M | 1.46% | 11,004 | 366.48M |
| 416 | FTH | Faeth Therapeutics, Inc. | 826.89M | -0.31% | 433,893 | - |
| 417 | ACHV | Achieve Life Sciences, Inc. | 822.19M | -0.37% | 970,833 | - |
| 418 | AURA | Aura Biosciences, Inc. | 808.90M | 0.39% | 500,879 | - |
| 419 | OCS | Oculis Holding AG | 807.76M | -0.42% | 76,441 | 1.45M |
| 420 | SLN | Silence Therapeutics plc | 798.98M | 0.76% | 740,545 | 615.00K |
| 421 | AHG | Akso Health Group | 796.48M | -8.85% | 11,125 | 13.83M |
| 422 | DRUG | Bright Minds Biosciences Inc. | 783.53M | -1.45% | 165,838 | - |
| 423 | HELP | Cybin Inc. | 780.38M | 0.96% | 2,160,115 | - |
| 424 | VREX | Varex Imaging Corporation | 780.16M | 0.11% | 953,788 | 865.00M |
| 425 | NGNE | Neurogene Inc. | 773.04M | 1.68% | 346,579 | 925.00K |
| 426 | NVCT | Nuvectis Pharma, Inc. | 767.62M | 0.90% | 196,956 | - |
| 427 | STTK | Shattuck Labs, Inc. | 755.74M | 3.86% | 475,542 | 1.00M |
| 428 | AHCO | AdaptHealth Corp. | 751.09M | 4.45% | 1,917,664 | 3.36B |
| 429 | PHR | Phreesia, Inc. | 749.16M | 1.00% | 759,873 | 495.59M |
| 430 | SOPH | SOPHiA GENETICS SA | 736.36M | 3.84% | 422,154 | 86.17M |
| 431 | TECX | Tectonic Therapeutic, Inc. | 735.64M | 4.38% | 188,531 | - |
| 432 | CBIO | Crescent Biopharma, Inc. | 734.04M | 5.67% | 218,361 | 11.88M |
| 433 | GYRE | Gyre Therapeutics, Inc. | 732.69M | -1.57% | 65,998 | 109.82M |
| 434 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 727.98M | - | 170,945 | - |
| 435 | MNPR | Monopar Therapeutics Inc. | 723.04M | -2.85% | 176,419 | - |
| 436 | ALLO | Allogene Therapeutics, Inc. | 722.08M | -0.48% | 3,932,161 | 4.64M |
| 437 | SSII | SS Innovations International, Inc. | 718.38M | -0.69% | 62,221 | 52.40M |
| 438 | CTMX | CytomX Therapeutics, Inc. | 714.71M | -0.30% | 2,894,667 | 18.30M |
| 439 | IRWD | Ironwood Pharmaceuticals, Inc. | 708.88M | 3.62% | 2,272,204 | 389.32M |
| 440 | RGNX | REGENXBIO Inc. | 707.66M | -3.07% | 857,803 | 174.48M |
| 441 | ZVRA | Zevra Therapeutics, Inc. | 704.89M | -0.17% | 703,970 | 136.07M |
| 442 | PHAT | Phathom Pharmaceuticals, Inc. | 704.54M | 3.14% | 979,107 | 239.66M |
| 443 | ASMB | Assembly Biosciences, Inc. | 700.00M | 2.54% | 341,472 | 74.85M |
| 444 | EVO | Evotec SE | 696.39M | -1.53% | 40,868 | 819.47M |
| 445 | PRLD | Prelude Therapeutics Incorporated | 682.86M | 2.00% | 516,137 | 22.42M |
| 446 | KIDS | OrthoPediatrics Corp. | 669.72M | -2.21% | 364,622 | 252.72M |
| 447 | STLN | Starling Oncology, Inc. | 658.89M | -1.15% | 1,529,285 | 587.24M |
| 448 | VALN | Valneva SE | 656.66M | 2.05% | 21,593 | 163.30M |
| 449 | TLRY | Tilray Brands, Inc. | 656.37M | 3.64% | 4,294,722 | 915.45M |
| 450 | AGMB | AgomAb Therapeutics NV | 652.54M | -1.34% | 68,360 | - |
| 451 | ANGO | AngioDynamics, Inc. | 650.99M | -0.44% | 150,064 | 320.17M |
| 452 | CTNM | Contineum Therapeutics, Inc. | 646.71M | 7.30% | 353,837 | - |
| 453 | SCTX | Scribe Therapeutics Inc. | 643.84M | 3.96% | 179,389 | 36.28M |
| 454 | AUTL | Autolus Therapeutics plc | 641.45M | -2.03% | 2,410,347 | 117.39M |
| 455 | CRMD | CorMedix Inc. | 639.14M | -0.36% | 1,496,583 | 462.25M |
| 456 | SGMT | Sagimet Biosciences Inc. | 637.13M | 0.69% | 1,022,174 | - |
| 457 | CTEV | Claritev Corporation | 631.63M | 9.36% | 160,428 | 994.67M |
| 458 | MDXG | MiMedx Group, Inc. | 631.14M | 0.70% | 896,718 | 355.17M |
| 459 | OABI | OmniAb, Inc. | 629.54M | 0.70% | 1,698,228 | 38.46M |
| 460 | CTKB | Cytek Biosciences, Inc. | 625.22M | 3.22% | 820,031 | 206.71M |
| 461 | VSTM | Verastem, Inc. | 623.98M | 1.03% | 994,940 | 87.53M |
| 462 | EIKN | Eikon Therapeutics, Inc. | 616.94M | 5.95% | 532,767 | - |
| 463 | ARVN | Arvinas, Inc. | 612.34M | 3.77% | 951,751 | 316.70M |
| 464 | BWAY | BrainsWay Ltd. | 605.12M | -1.54% | 47,251 | 60.70M |
| 465 | ALT | Altimmune, Inc. | 604.95M | 5.42% | 6,150,550 | 31.00K |
| 466 | PRME | Prime Medicine, Inc. | 603.10M | 4.63% | 3,597,004 | 4.07M |
| 467 | DCTH | Delcath Systems, Inc. | 594.74M | 2.33% | 508,956 | 95.42M |
| 468 | AQST | Aquestive Therapeutics, Inc. | 584.88M | 3.67% | 2,015,716 | 54.09M |
| 469 | WEAV | Weave Communications, Inc. | 583.19M | - | 4,417,602 | 257.79M |
| 470 | CERS | Cerus Corporation | 566.28M | 0.72% | 2,489,701 | 221.55M |
| 471 | ZURA | Zura Bio Limited | 560.60M | 1.74% | 640,665 | - |
| 472 | ENTX | Entera Bio Ltd. | 559.25M | 0.31% | 441,147 | 42.00K |
| 473 | EOLS | Evolus, Inc. | 554.16M | 0.48% | 582,678 | 316.49M |
| 474 | SRTA | Strata Critical Medical, Inc. | 552.03M | 4.70% | 1,050,345 | 255.98M |
| 475 | FLGT | Fulgent Genetics, Inc. | 547.55M | -0.10% | 323,956 | 323.93M |
| 476 | SPRY | ARS Pharmaceuticals, Inc. | 547.46M | - | 1,267,918 | 116.93M |
| 477 | OVID | Ovid Therapeutics Inc. | 546.83M | 2.19% | 1,331,894 | 1.58M |
| 478 | TCMD | Tactile Systems Technology, Inc. | 539.58M | 1.66% | 356,495 | 350.31M |
| 479 | EVH | Evolent Health, Inc. | 535.90M | 0.85% | 1,652,392 | 2.10B |
| 480 | ARTV | Artiva Biotherapeutics, Inc. | 534.37M | -1.89% | 199,277 | 251.00K |
| 481 | RZLT | Rezolute, Inc. | 531.74M | 9.23% | 6,499,808 | - |
| 482 | CABA | Cabaletta Bio, Inc. | 530.68M | -1.88% | 4,402,916 | - |
| 483 | KYTX | Kyverna Therapeutics, Inc. | 520.72M | 3.57% | 663,596 | - |
| 484 | MPLT | MapLight Therapeutics, Inc. | 519.90M | -0.18% | 435,204 | - |
| 485 | SENS | Senseonics Holdings, Inc. | 513.41M | 10.09% | 1,280,022 | 48.55M |
| 486 | EVMN | Evommune, Inc. | 508.82M | 3.32% | 272,876 | 10.00M |
| 487 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 488 | BLSM | BlossomHill Therapeutics, Inc. | 501.94M | 3.67% | 111,382 | - |
| 489 | DNA | Ginkgo Bioworks Holdings, Inc. | 498.32M | 6.32% | 1,429,546 | 132.42M |
| 490 | RLMD | Relmada Therapeutics, Inc. | 493.88M | -0.22% | 985,171 | - |
| 491 | CCCC | C4 Therapeutics, Inc. | 492.10M | -0.74% | 1,160,616 | 35.04M |
| 492 | NRC | NRC Health | 490.83M | 1.70% | 339,033 | 140.00M |
| 493 | PROK | ProKidney Corp. | 486.74M | 13.38% | 1,675,014 | 818.00K |
| 494 | PRTA | Prothena Corporation plc | 485.13M | 4.65% | 376,042 | 54.53M |
| 495 | NPCE | NeuroPace, Inc. | 481.57M | 0.07% | 115,976 | 106.99M |
| 496 | EDIT | Editas Medicine, Inc. | 477.63M | 5.78% | 2,109,021 | 47.01M |
| 497 | PBYI | Puma Biotechnology, Inc. | 476.97M | 1.43% | 333,531 | 231.24M |
| 498 | QTTB | Q32 Bio Inc. | 475.42M | 0.69% | 341,346 | 53.74M |
| 499 | OCGN | Ocugen, Inc. | 471.36M | - | 2,436,518 | 4.58M |
| 500 | CLPT | ClearPoint Neuro, Inc. | 469.46M | 1.32% | 560,440 | 42.28M |